NSRX
AMEX
$3.01
Nasus Pharma Ltd (NSRX)
Nasus Pharma Ltd. is a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company is headquartered in Tel Aviv-Yafo, Israel.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Strong Buy
Target: $19.67 (+553.49%)
Market Cap
$28M
Free Cash Flow Yield
-17.55%
Beta (5Y)
0.83
Price Chart
Valuation
Market Cap$28M
P/B12.90
Profitability
Total Revenue (TTM)$1.24B
EBITDA-$5.93M
Profit Margin-0.5%
Operating Margin-0.4%
EPS-$0.65
Financial Health
Free Cash Flow Yield-17.55%
Growth & Risk
Beta (5Y)0.83
Sharpe Ratio-0.56